Related Experiment Videos
Comparative genomics on ROR1 and ROR2 orthologs.
1M&M Medical BioInformatics, Hongo 113-0033, Japan.
Oncology Reports
|October 8, 2005
Summary
ROR1 and ROR2 are transmembrane receptors crucial for WNT signaling. Comparative analysis reveals conserved domains and distinct expression patterns, highlighting their roles in stem cell biology and oncology.
Area of Science:
- Molecular Biology
- Genomics
- Bioinformatics
Background:
- Transmembrane proteins with extracellular Frizzled domains, including ROR1 and ROR2, are vital components of the WNT signaling network.
- These receptors play significant roles in various biological processes and are implicated in diseases.
Purpose of the Study:
- To perform comparative integromics analyses of ROR1 and ROR2 orthologs.
- To investigate the evolutionary conservation and expression patterns of ROR1 and ROR2.
Main Methods:
- Bioinformatic comparative integromics analyses.
- Identification and characterization of zebrafish ror2 gene and its mRNA.
- Amino acid identity and domain conservation analysis across vertebrate orthologs.
- Analysis of ROR1 and ROR2 mRNA expression patterns in various human tissues and cancers.
Main Results:
- Zebrafish ror2 gene identified, encoding a 939-aa protein with high identity to human ROR2 and ROR1.
- Key domains (Immunoglobulin-like, Frizzled, Kringle, tyrosine kinase, RORHC) are conserved in vertebrate ROR1 and ROR2 orthologs.
- SH2 binding site conserved in ROR2 but not ROR1 orthologs.
- ROR1 mRNA expressed in ES cells, infant brain, renal and colon cancer; ROR2 mRNA in parathyroid, testis, uterus, and gastric cancer.
- ROR2 promoter shows greater evolutionary conservation than ROR1 promoter.
- Co-expression of WNT5A and ROR receptors in ES cells and gastric cancer implicates them in the planar cell polarity pathway.
Conclusions:
- ROR1 and ROR2 exhibit conserved structural features and distinct tissue-specific expression profiles.
- The differential expression and conserved domains suggest specialized roles in WNT signaling, stem cell biology, and oncology.
- ROR1 and ROR2 represent potential pharmacogenomic targets for stem cell applications and cancer therapies.